BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 9184145)

  • 1. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes.
    Gorgani NN; Parish CR; Easterbrook Smith SB; Altin JG
    Biochemistry; 1997 Jun; 36(22):6653-62. PubMed ID: 9184145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system.
    Manderson GA; Martin M; Onnerfjord P; Saxne T; Schmidtchen A; Mollnes TE; HeinegÄrd D; Blom AM
    Mol Immunol; 2009 Oct; 46(16):3388-98. PubMed ID: 19674792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX; Siegel JN; Gewurz H
    J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A heme- and metal-binding hexapeptide from the sequence of rabbit plasma histidine-rich glycoprotein.
    Morgan WT; Deaciuc V; Riehm JP
    J Mol Recognit; 1989 Nov; 2(3):122-6. PubMed ID: 2636901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A stable conformer of IgG, prepared by an acidic influence: study by calorimetry, binding of the C1q complement component, and monospecific anti-IgG].
    Kravchuk ZI; Vlasov AP; Liakhnovich GV; Martsev SP
    Biokhimiia; 1994 Oct; 59(10):1458-77. PubMed ID: 7819387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The formation of insoluble immune complexes between ovalbumin and anti-ovalbumin IgG occurs in at least two distinct phases dependent on reactant concentration and ionic strength.
    Gorgani NN; Easterbrook-Smith SB; Altin JG
    Biochim Biophys Acta; 1996 Oct; 1317(1):45-54. PubMed ID: 8876626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y; Tamura N; Fujita T
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P; Nicholson-Weller A; Wessels MR
    J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
    Russell MW; Reinholdt J; Kilian M
    Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histidine-rich glycoprotein prevents the formation of insoluble immune complexes by rheumatoid factor.
    Gorgani NN; Altin JG; Parish CR
    Immunology; 1999 Nov; 98(3):456-63. PubMed ID: 10583608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells.
    van den Dobbelsteen ME; van der Woude FJ; Schroeijers WE; Klar-Mohamad N; van Es LA; Daha MR
    J Immunol; 1993 Oct; 151(8):4315-24. PubMed ID: 8409404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histidine-rich glycoprotein modulation of immune/autoimmune, vascular, and coagulation systems.
    Blank M; Shoenfeld Y
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):307-12. PubMed ID: 18219588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histidine-rich glycoprotein regulates the binding of monomeric IgG and immune complexes to monocytes.
    Gorgani NN; Altin JG; Parish CR
    Int Immunol; 1999 Aug; 11(8):1275-82. PubMed ID: 10421785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanisms of degradation of C1q in vivo and in vitro: role of macrophages.
    Daha MR
    Behring Inst Mitt; 1989 Jul; (84):42-6. PubMed ID: 2529843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histidine-rich glycoprotein binds to cell-surface heparan sulfate via its N-terminal domain following Zn2+ chelation.
    Jones AL; Hulett MD; Parish CR
    J Biol Chem; 2004 Jul; 279(29):30114-22. PubMed ID: 15138272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q.
    Zlatarova AS; Rouseva M; Roumenina LT; Gadjeva M; Kolev M; Dobrev I; Olova N; Ghai R; Jensenius JC; Reid KB; Kishore U; Kojouharova MS
    Biochemistry; 2006 Aug; 45(33):9979-88. PubMed ID: 16906756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of human C1q with IgG and IgM: revisited.
    Gadjeva MG; Rouseva MM; Zlatarova AS; Reid KB; Kishore U; Kojouharova MS
    Biochemistry; 2008 Dec; 47(49):13093-102. PubMed ID: 19006321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
    Atkins KL; Burman JD; Chamberlain ES; Cooper JE; Poutrel B; Bagby S; Jenkins AT; Feil EJ; van den Elsen JM
    Mol Immunol; 2008 Mar; 45(6):1600-11. PubMed ID: 18061675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.